Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.23.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2022     16,970,120     $ 0.119  
Granted    
-
      
-
  
Shares vested    
-
      
-
  
Non-vested, March 31, 2023     16,970,120     $ 0.119  

 
Schedule of stock option activities
    Number of
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding, December 31, 2022     8,445,698     $ 0.40       3.43      
       -
  
Exercised    
-
      
-
      
-
      
-
  
Balance Outstanding, March 31, 2023     8,445,698     $ 0.40       3.18     $
-
  
Exercisable, March 31, 2023     8,445,698     $ 0.40       3.18     $
-
  

 
Schedule of warrant activities
    Number of
Warrants		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding December 31, 2022     34,000,000     $ 0.011       3.73     $
      -
  
Granted    
-
      
-
      
-
      
-
  
Balance Outstanding March 31, 2023     34,000,000     $ 0.011       3.48     $
-
  
Exercisable, March 31, 2023     34,000,000     $ 0.011       3.48     $
-